BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Peregrine Pharmaceuticals, Inc. 

14272 Franklin Avenue, Suite 100

Tustin  California  92780  U.S.A.
Phone: 714-508-6000 Fax: 714-838-5817


SEARCH JOBS




Collaborations

AVANIR Pharmaceuticals 





 Company News
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Completion of Patient Enrollment in Breast Cancer Clinical Trial for Bavituximab 4/30/2013 11:24:05 AM    More...
Data Presented at American Association for Cancer Research Annual Meeting Support Targeted Immune Reactivation Mechanism and Potential of Peregrine Pharmaceuticals, Inc. (PPHM)'s Bavituximab in Solid Tumor Therapy 4/10/2013 11:57:19 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Three Abstracts Accepted for Presentation at American Association for Cancer Research 2013 Annual Meeting 4/2/2013 9:20:38 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Third Quarter Fiscal Year 2013 Financial Results and Recent Developments 3/13/2013 8:26:59 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) to Report Third Quarter Fiscal Year 2013 Financial Results After Market Close on March 12, 2013 3/6/2013 9:33:29 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Participation at Upcoming Investor Conferences 2/27/2013 10:47:27 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Positive Results From Revised Lung Cancer Trial Data 2/19/2013 7:34:58 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Results From Phase II Clinical Trial of Bavituximab in Stage IV Pancreatic Cancer 2/13/2013 9:52:48 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) Provides Update on the Internal Review of Its Phase II Second-Line Non-Small Cell Lung Cancer Trial 1/7/2013 10:20:00 AM    More...
Peregrine Pharmaceuticals, Inc. (PPHM) Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement 12/12/2012 8:53:47 AM    More...
12345678910...